Transmission of HIV: Study spotlights virus that starts infection

(Medical Xpress) -- When HIV is transmitted from one person to another, the virus faces a genetic "bottleneck." This means that usually during heterosexual transmission, only one virus out of a swarm of frequently mutating viruses establishes the new infection.

Now Emory Vaccine Center researchers have shown that the that starts an individual’s new differs markedly from the dominant strains in his or her partner’s genital tract. This suggests that the process of transmission favors some viral variants, and the bottleneck effect doesn’t arise simply by chance or through what types of virus flourish better in the genital tract.

The results are published online this week in Proceedings of the National Academy of Sciences, Early Edition.

“If the success of the establishing virus came only by chance, most of the time it would be one of the viruses that is most abundant in the donor’s genital tract. But we don’t see that,” says senior author Eric Hunter, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine. “What we see suggests that transmission is selecting for certain viruses. The virus establishing the infection is a single variant, but that variant is different for each transmission event.”

The first author of the paper is senior scientist Debrah Boeras, PhD, now at the Centers for Disease Control and Prevention. Dr. Hunter is co-director of Emory’s Center for AIDS Research and a Georgia Research Alliance Eminent Scholar. Emory co-authors include Susan Allen, MD, MPH, professor of pathology and laboratory medicine and Cynthia Derdeyn, PhD, associate professor of pathology and laboratory medicine in Emory School of Medicine. Collaborators from Los Alamos National Laboratory contributed to the paper.

Access to patient samples came through collaboration with co-investigators and volunteers at Emory’s HIV research programs in Rwanda and Zambia. The researchers obtained vaginal swabs, semen, and blood samples from eight consenting heterosexual couples in Rwanda and Zambia at the time the newly infected partners were diagnosed as HIV-positive. Of the eight instances of infection, six involved female-to-male transmission.

Boeras and her colleagues determined the DNA sequences for the viruses’ env gene, which encodes a protein forming the outer coat of the virus. They found that a single genetic variant in the genital tracts of the donor established an infection in the recipient.

Hunter emphasized that the paper’s results are the starting point for a detailed study of the distinguishing features of viruses that initiate infection.

“There is clearly a lot of work still to do,” he says. The big challenge now is to understand the features of the viruses that start an infection, and target them with microbicides or vaccines. It could help us be much smarter in how we try to protect people.”

Other studies have already shown that “founder” viruses have Env proteins that are more compact and have fewer sites that can be modified with sugars, which may affect how these viruses interact with genital tissue in the uninfected partner.

This topic is the focus of current research in the Hunter laboratory, and their results could inform design of a still-elusive vaccine.

More information: D.I. Boeras et al. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. PNAS Early Edition (2011)

Related Stories

New hope for hep C vaccine

date Sep 13, 2011

Hopes for an effective vaccine and treatment against the potentially fatal hepatitis C infection have received a major boost following the discovery of two 'Achilles' heels' within the virus.

Recommended for you

HIV reservoirs remain obstacles to cure

date May 19, 2015

Antiretroviral therapy (ART) has proven lifesaving for people infected with HIV; however, the medications are a lifelong necessity for most HIV-infected individuals and present practical, logistical, economic ...

Microclinics help keep Kenyan HIV patients in care

date May 18, 2015

A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics—an innovative intervention ...

'Redesigned' antibodies may control HIV

date May 18, 2015

With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.